NEMASOL SODIUM TAB 500MG 500 MG
SODIUM PARA-AMINOSALICYLATE : 500 MG · DIN 00236691 · ICN CANADA LTD.
Health Canada status: CANCELLED POST MARKET
What is NEMASOL SODIUM TAB 500MG?
NEMASOL SODIUM TAB 500MG 500 MG contains SODIUM PARA-AMINOSALICYLATE : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 00236691, held by ICN CANADA LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Apr-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00236691 |
|---|---|
| Brand name | NEMASOL SODIUM TAB 500MG |
| Generic / active ingredient | SODIUM PARA-AMINOSALICYLATE : 500 MG |
| Manufacturer | ICN CANADA LTD. |
| Strength | 500 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J04AA02 SODIUM AMINOSALICYLATE |
| AHFS class | 08:16.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Apr-2005 |
| Original market date | 1966-12-31 00:00:00 |
Is SODIUM AMINOSALICYLATE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Who else supplies SODIUM AMINOSALICYLATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SODIUM AMINOSALICYLATE appears in 5432 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.